From: Gout-related inpatient utilization: a study of predictors of outcomes and time trends
Univariate | Multivariable-adjusted | |||
---|---|---|---|---|
Odds ratio (95 % CI) | P value | Odds ratio (95 % CI) | P value | |
Age | ||||
<50 | Ref | |||
50 to <65 | 0.53 (0.38, 0.73) | 0.0001 | 0.69 (0.47, 1.01) | 0.0573 |
65 to <80 | 0.15 (0.11, 0.20) | <0.0001 | 0.25 (0.16, 0.37) | <0.0001 |
≥80 | 0.08 (0.06, 0.11) | <0.0001 | 0.13 (0.09, 0.20) | <0.0001 |
Gender | ||||
Female | Ref | Ref | ||
Male | 1.81 (1.55, 2.12) | <0.0001 | 1.16 (0.97, 1.39) | 0.1128 |
Median household income | ||||
1st quartile (<$38,999) | Ref | Ref | ||
2nd quartile ($39,000 to $47,999) | 1.05 (0.85, 1.31) | 0.6413 | 1.12 (0.87, 1.44) | 0.3930 |
3rd quartile ($48,000 to $62,999) | 0.89 (0.70, 1.12) | 0.2998 | 1.02 (0.77, 1.36) | 0.8844 |
4th quartile ($63,000 or more) | 0.81 (0.64, 1.01) | 0.0618 | 1.09 (0.84, 1.42) | 0.5083 |
Primary payer | ||||
Medicare | Ref | Ref | ||
Medicaid | 3.82 (2.92, 5.00) | <0.0001 | 1.49 (1.00, 2.24) | 0.0527 |
Private insurance | 3.28 (2.62, 4.11) | <0.0001 | 1.29 (1.00, 1.67) | 0.0523 |
Self-pay/no charge | 11.42 (7.30, 17.85) | <0.0001 | 2.77 (1.54, 4.96) | 0.0006 |
Other | 4.59 (2.50, 8.42) | <0.0001 | 1.49 (0.79, 2.81) | 0.2218 |
Patient location (residence) | ||||
Micropolitan/not metro | Ref | Ref | ||
Metropolitan (large or small) | 0.84 (0.67, 1.07) | 0.1589 | 0.72 (0.54, 0.97) | 0.0282 |
Hospital region | ||||
Northeast | Ref | Ref | ||
Midwest | 1.17 (0.89, 1.54) | 0.2682 | 0.98 (0.73, 1.31) | 0.8700 |
South | 1.28 (1.00, 1.62) | 0.0477 | 1.20 (0.90, 1.59) | 0.2138 |
West | 1.58 (1.17, 2.13) | 0.0028 | 1.24 (0.91, 1.69) | 0.1821 |
Teaching status of hospital | ||||
Metropolitan non-teaching or non-metro | Ref | Ref | ||
Metropolitan teaching | 1.04 (0.86, 1.24) | 0.7066 | 1.09 (0.89, 1.34) | 0.3909 |
Comorbidities | ||||
Coronary heart disease (ref: no) | 0.58 (0.48, 0.69) | <0.0001 | 0.94 (0.75, 1.16) | 0.5433 |
Hyperlipidemia (ref: no) | 0.89 (0.78, 1.03) | 0.1152 | 1.18 (0.99, 1.39) | 0.0604 |
Renal failure (ref: no) | 0.61 (0.52, 0.73) | <0.0001 | 0.87 (0.71, 1.06) | 0.1528 |
Heart failure (ref: no) | 0.52 (0.44, 0.61) | <0.0001 | 0.88 (0.72, 1.07) | 0.2002 |
Hypertension (ref: no) | 0.77 (0.64, 0.93) | 0.0050 | 1.09 (0.86, 1.39) | 0.4554 |
Diabetes (ref: no) | 0.68 (0.58, 0.78) | <0.0001 | 0.78 (0.64, 0.95) | 0.0121 |
COPD (ref: no) | 0.58 (0.46, 0.72) | <0.0001 | 0.79 (0.60, 1.04) | 0.0871 |
Osteoarthritis (ref: no) | 0.60 (0.49, 0.74) | <0.0001 | 0.85 (0.68, 1.06) | 0.1414 |
Length of stay, in days (per day increase) | 0.79 (0.76, 0.83) | <0.0001 | 0.80 (0.76, 0.83) | <0.0001 |